Announcement on Expected Increase in Performance for 2025
Filed with SSE · · 2 pages · Chinese
Ningbo Menovo Pharmaceutical Co., Ltd. on 6ix
Earlier from Ningbo Menovo Pharmaceutical
- Announcement on the Subsidiary Re-certified as High-tech Enterprise
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Adempas Riociguat Tablets
- Indicative Announcement on the Expected Meeting of Conditions for Downward Correction of Conversion Price for "Menovo Convertible Bonds"
- in 2026
Later from Ningbo Menovo Pharmaceutical
- Announcement on the Holding Subsidiary Re-certified as High-tech Enterprise
- Announcement on Relocation of Company Office Premises
- Announcement on Not Revising the Downward Conversion Price of "Menovo Convertible Bonds"
- Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks
- Announcement on Selection of Products of the Wholly-owned Subsidiary for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
Follow Ningbo Menovo Pharmaceutical into a list and get an email when it puts out news.
Follow Ningbo Menovo Pharmaceutical